Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.2(PAH):c.796A>C (p.Thr266Pro)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA267673

120286 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 9d15f844-7f1a-47ea-91e3-fa8a96d0342c

Approved on: 2018-12-10

Published on: 2019-04-05

HGVS expressions

NM_000277.2:c.796A>C

NM_000277.2(PAH):c.796A>C (p.Thr266Pro)

NC_000012.12:g.102852861T>G

CM000674.2:g.102852861T>G

NC_000012.11:g.103246639T>G

CM000674.1:g.103246639T>G

NC_000012.10:g.101770769T>G

NG_008690.1:g.69742A>C

NG_008690.2:g.110550A>C

NM_000277.1:c.796A>C

NM_001354304.1:c.796A>C

NM_000277.3:c.796A>C

ENST00000307000.7:c.781A>C

ENST00000549247.6:n.555A>C

ENST00000553106.5:c.796A>C

Likely Pathogenic

PP4_Moderate PM3 PM2 PP3

PM5

Evidence Links 2

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.796A>C (p.Thr266Pro) variant in PAH is reported in 1 classic PKU patient with BH4 deficiency excluded. (PMID: 26666653, 23430918) It was detected with p.V190A, which is interpreted as pathogenic by our PAH VCEP. (PMID: 23430918) This variant is absent from ExAC, gnomAD, 1000G, and ESP. It is predicted deleterious in SIFT, Polyphen-2, MutationTaster, and REVEL=0.98. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PP4_Moderate, PM3, PP3.

PP4_Moderate

T266P idenitifed in 1 classic PKU patient. BH4 deficiency was excluded. PMID: 26666653, 23430918

A total of 364 French patients among which, 9 % had mild hyperphenylalaninemia, 17.7 % mild phenylketonuria and 73.1 % classical phenylketonuria had the PAH gene sequenced and analyzed by Multiplex Ligation Probe Amplification. p.Thr266P reported in 1 patient with classic PKU. Likely same patient as Sarkissian due to same reported genotype (V190A/T266P). PubMed:26666653

Prospectively enrolled phenylketonuria patients (n=485) participated in an international Phase II clinical trial to identify the prevalence of a therapeutic response to daily doses of sapropterin dihydrochloride. T266P was identified in 1 patient. Patients with a diagnosis of primary BH4 deficiency were excluded from the study. PubMed:23430918

PM3

Detected with V190A, Pathogenic per ClinGen Metabolic workgroup. PMID: 23430918

PAH genotype: p.V190A (VarID 102740, no clinical significance provided): p.T266P. PubMed:23430918

PM2

Absent from ExAC, gnomAD, 1000G, ESP

PP3

Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.98

PM5

T266L and T266A seen before, but no clinical significance reported in ClinVar.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.